| Type 1 n=3709 | Type 2 n=863 | p |
---|
Risk factors and comorbidities | Age, years | 67 [56-79] | 77 [65-84] | <0.001 | Female | 971 (26) | 382 (44) | <0.001 | BMI, kg/m² | 27 [24-30] | 26 [23-29] | <0.001 | Hypertension | 2151 (58) | 645 (75) | <0.001 | Hypercholesterolemia | 1788 (49) | 466 (51) | 0.01 | Family history of CAD | 1095 (30) | 209 (24) | <0.001 | Smoking | 1167 (32) | 143 (17) | <0.001 | Diabetes | 892 (24) | 300 (35) | <0.001 | Chronic renal failure | 171 (5) | 112 (13) | <0.001 | COPD | 243 (7) | 128 (15) | <0.001 | Neoplasia | 476 (13) | 179 (21) | <0.001 | Cardiovascular history | | | | CAD | 831 (23) | 322 (37) | <0.001 | Myocardial infarction | 319 (9) | 135 (16) | <0.001 | Stroke | 252 (7) | 119 (14) | <0.001 | PAD | 262 (7) | 138 (16) | <0.001 | Heart failure | 135 (4) | 113 (13) | <0.001 | Atrial fibrillation | 291 (8) | 209 (25) | <0.001 | Aortic stenosis | 111 (3) | 128 (15) | <0.001 | Chronic medication | | | | ACEI/ARB | 1413 (38) | 459 (53) | <0.001 | Beta blockers | 1075 (29) | 409 (47) | <0.001 | Statins | 1111 (30) | 368 (43) | <0.001 | Diuretics | 986 (27) | 461 (53) | <0.001 | Antiplatelet | 386 (10) | 177 (20) | <0.001 | Aspirin | 935 (25) | 346 (40) | <0.001 | VKA | 232 (6) | 171 (20) | <0.001 | Clinical data at admission | | | | Time SO-admission, min | 180 [100-480] | 150 [60-351] | <0.001 | Heart rate, b/min | 77 [66-90] | 85 [71-102] | <0.001 | SBP, mmHg | 140 [121-160] | 132 [114-156] | <0.001 | DBP, mmHg | 80 [70-94] | 73 [62-85] | <0.001 | Anterior wall location | 1351 (36) | 285 (33) | 0.06 | GRACE risk score | 143 [120-170] | 171 [138-197] | <0.001 | Heart failure | 812 (22) | 396 (46) | <0.001 | LVEF, % | 55 [45-60] | 50 [40-60] | <0.001 | ECG at admission | | | | STEMI | 1940 (52) | 209 (24) | <0.001 | AF/Flutter | 264 (9) | 162 (19) | <0.001 | LBBB | 195 (5) | 86 (10) | <0.001 | AVB | 91 (2) | 22 (1) | 0.003 | Biological data | | | | Hemoglobin, g/100mL | 14.4 [13-15.4] | 12.7 [10.8-14.2] | <0.001 | CRP, mg/L | 4.6 [2.9-12.0] | 13.9 [3.8-60.8] | <0.001 | Creatinine, µmol/L | 80 [70-102] | 92 [71-126] | <0.001 | GFR, mL/min/1.73m2 | 67 [54-108] | 54 [36-80] | <0.001 | LDL cholesterol, g/L | 1.2 [0.9-1.5] | 0.9 [0.6-1.2] | <0.001 | NT-proBNP, pg/mL | 578 [150-2334] | 3132 [729-10246] | <0.001 | Troponin Ic peak, µg/L | 17 [3-68] | 3 [1-14] | <0.001 | Coronary angiography | 3709 (100) | 662 (77) | <0.001 | Normal coronary arteries | 10 (0.3) | 144 (22) | <0.001 | MINOCA | 54 (1) | 245 (37) | <0.001 | 3-vessel or left main disease | 1157 (31) | 191 (29) | 0.2 | Revascularization | | | | PCI | 2980 (80) | 204 (24) | <0.001 | CABG | 229 (6) | 40 (5) | 0.1 | Thrombolysis | 230 (6) | 6 (0.7) | <0.001 | Hospital outcomes | | | | ICU stay, days | 4 [3-5] | 4 [3-6] | 0.05 | All cause death | 195 (5) | 92 (11) | <0.001 | Cardiovascular death | 182 (5) | 75 (9) | <0.001 |
|